FDA Nominee Addresses Vaccine Safety During Senate Hearing

Why it matters locally: Decisions and policies made by the FDA, especially concerning vaccine safety and childhood immunization initiatives, directly influence public health guidelines and medical practices for Kansans. These policies impact healthcare providers and residents across the state, including those served by organizations like Ascension Via Christi St. Francis in Wichita.

---

WASHINGTON – Heidi Overton, President Donald Trump's nominee to lead the Food and Drug Administration (FDA), spoke to senators Thursday during her confirmation hearing. Overton addressed the safety of long-established vaccines. Senators questioned Overton on the White House's initiatives regarding childhood immunizations. Her testimony followed President Trump's nomination for the FDA's top role.